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Summary
 
The natural resistance associated macrophage protein (
 
Nramp
 
) gene family is composed of two
members in mammals, 
 
Nramp1
 
 and 
 
Nramp2. Nramp1
 
 is expressed primarily in macrophages and
mutations at this locus cause susceptibility to infectious diseases. 
 
Nramp2
 
 has a much broader
range of tissue expression and mutations at 
 
Nramp2
 
 result in iron deficiency, indicating a role
for Nramp2 in iron metabolism. To get further insight into the function and mechanism of ac-
tion of Nramp proteins, we have generated isoform specific anti-Nramp1 and anti-Nramp2 an-
tisera. Immunoblotting experiments indicate that Nramp2 is present in a number of cell types,
including hemopoietic precursors, and is coexpressed with Nramp1 in primary macrophages
and macrophage cell lines. Nramp2 is expressed as a 90–100-kD integral membrane protein ex-
tensively modified by glycosylation (
 
.
 
40% of molecular mass). Subcellular localization studies
by immunofluorescence and confocal microscopy indicate distinct and nonoverlapping local-
ization for Nramp1 and Nramp2. Nramp1 is expressed in the lysosomal compartment, whereas
Nramp2 is not detectable in the lysosomes but is expressed primarily in recycling endosomes
and also, to a lower extent, at the plasma membrane, colocalizing with transferrin. These find-
ings suggest that Nramp2 plays a key role in the metabolism of transferrin-bound iron by trans-
porting free Fe
 
2
 
1
 
 across the endosomal membrane and into the cytoplasm.
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N
 
aturally occurring (1) or experimentally induced (2)
mutations at the 
 
Nramp1
 
 (natural resistance associated
macrophage protein 1)
 
1
 
 locus in vivo impair macrophage
function and cause susceptibility to infection by intracellu-
lar pathogens such as 
 
Salmonella
 
, 
 
Leishmania
 
, and 
 
Mycobacte-
rium
 
 in mice. In humans, polymorphic variants at 
 
Nramp1
 
are associated with increased susceptibility to tuberculosis
and leprosy (3, 4). Studies in vitro in explanted cell popula-
tions have indicated that mutations at 
 
Nramp1
 
 affect the
ability of the macrophage to restrict the intracellular repli-
cation of antigenically unrelated microorganisms. We
cloned the 
 
Nramp1
 
 gene (5) and showed that its mRNA is
expressed abundantly in macrophages (6) and in neutro-
phils (7) and is inducible in macrophages by exposure to
cytokines and bacterial endotoxin (6). Predicted amino acid
sequence analysis indicates that Nramp1 has many char-
acteristics of an integral membrane transport protein in-
cluding 12 putative transmembrane (TM) domains, several
predicted N-linked glycosylation sites, and a sequence sig-
nature previously identified in a number of eukaryotic and
prokaryotic transport proteins (5). In macrophages, direct
biochemical studies have shown that Nramp1 is a mem-
brane phosphoglycoprotein of apparent mass 90–110 kD
(8), which is expressed in the Lamp1-positive lysosomal
compartment (9). Moreover, studies in phagosomes con-
taining either latex beads or intact bacteria have shown that
upon phagocytosis, Nramp1 is recruited to the membrane
of the phagosome, where it remains during its maturation
to phagolysosome (9). These findings suggest that Nramp1
may affect resistance to infection by modulating the intra-
vesicular milieu of the bacterial phagosome.
We have identified a second 
 
Nramp
 
 gene in mammals,
 
Nramp2
 
, which encodes a protein highly similar to Nramp1
(78% identity over the hydrophobic core) (10). As opposed
to the phagocyte-specific expression of 
 
Nramp1
 
, 
 
Nramp2
 
mRNA expression has been detected in most tissues and
 
1
 
Abbreviations used in this paper:
 
 CHO, Chinese hamster ovary; CHON,
Nramp-transfected CHO cells; Endo H, Endo-
 
b
 
-acetylglucosaminidase
H; GST, glutathione S-transferase; MEL, erythroleukemia; Nramp, natu-
ral resistance associated macrophage protein; TM, transmembrane. 
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cell types analyzed (10–12). Recently, it was shown that
the 
 
Nramp2
 
 gene is mutated (G185R) in two animal mod-
els of iron deficiency, the 
 
mk
 
 mouse (13) and the 
 
Belgrade
 
rat (14). The 
 
mk
 
 mouse displays deficiency in intestinal iron
uptake and microcytic anemia (15, 16). The 
 
Belgrade
 
 rat
also shows a defect in intestinal iron absorption (17). More-
over, studies in oocytes have shown that Nramp2 can
transport a number of divalent cations such as Fe
 
2
 
1
 
, Zn
 
2
 
1
 
,
and Mn
 
2
 
1
 
 in a pH-dependent, electrogenic fashion associ-
ated with the symport of a single proton (12). In addition,
transient overexpression of the wild type but not G185R
 
Nramp2
 
 in HEK293T cells results in a robust stimulation of
cellular 
 
55
 
Fe uptake (15). Taken together, these results indi-
cate that Nramp2 is the transferrin-independent system re-
sponsible for dietary iron absorption in the intestine. How-
ever, the ubiquitous expression of 
 
Nramp2
 
 mRNA suggests
that it may be involved in iron metabolism in other tissues
as well. As opposed to Nramp1, where the cellular and
subcellular localization of the protein have been estab-
lished, the lack of isoform-specific, anti-Nramp2 antibodies
has precluded the identification of the cell type and of the
subcellular compartment expressing this protein. Such in-
formation is critical to elucidate the role of the Nramp2
protein in cellular iron metabolism. In particular, the dem-
onstrated H
 
1
 
-driven, Fe
 
2
 
1
 
 transport activity of Nramp2, as
well as its expression in a wide variety of tissues, make it a
likely candidate not only for transferrin-independent iron
absorption in the intestine but also for the transferrin-
dependent uptake of iron in peripheral tissues. It is well es-
tablished that acidification of the endosomal compartment
causes Fe
 
3
 
1
 
 release from transferrin and that reductases then
convert the Fe
 
3
 
1
 
 to Fe
 
2
 
1
 
, but the mechanism of transport
of Fe
 
2
 
1
 
 across the endosomal membrane has not yet been
elucidated.
 
Materials and Methods
 
Immunogens.
 
For the production of isoform-specific poly-
clonal antisera directed against Nramp2, rabbits were immunized
with fusion proteins containing glutathione S-transferase (GST)
fused to a peptide segment derived from the amino terminal re-
gion of Nramp2 (residues 1–71; for amino acid numbering see
reference 10). This peptide is in a region of the protein which is
not conserved in other Nramp family members, including
Nramp1 (18). The GST–Nramp2 fusion protein was constructed
in the plasmid vector pGEX (Pharmacia) as follows: The Nramp2
sequence was amplified by PCR using oligonucleotides NF2 (5
 
9
 
-
AAAGATCTATGGTGTTGGATCC-3
 
9
 
) and NR (5
 
9
 
-CTGAA-
TTCGAACGCCCAGAGT-3
 
9
 
) (nucleotides 1–268), and the
full-length 
 
Nramp2
 
 cDNA as template. The PCR product was
digested with BglII and EcoRI and the fragment was subcloned
into pGEX digested with BamHI and EcoRI to create the in-
frame GST fusion protein. Overexpression of the Nramp2–GST
fusion protein was carried out in large scale cultures of 
 
Escherichia
coli
 
 and the protein was purified from bacterial lysates using glu-
tathione–Sepharose 4B (Pharmacia) as previously described (19).
Purified proteins were analyzed by 7.5% SDS-PAGE and excised
from the gel after light staining with 0.05% Coomassie blue in
ddH
 
2
 
O.
 
Production of Anti-Nramp2 Antibodies.
 
Polyclonal antibodies
were produced in male New Zealand White rabbits as described
previously (8). A system for affinity purification of the antibodies
was devised using the same Nramp2 peptide fused to a second fu-
sion partner, dihydrofolate reductase modified by the addition of
eight consecutive histidine residues (his–DHFR). The fusion
protein construct was made as described above, except the PCR
product was digested with EcoRI and the resulting overhangs re-
paired using the Klenow fragment of DNA polymerase I (Phar-
macia) before digestion with BglII. The digested PCR product
was ligated into BglII- and SmaI-digested pQE40 plasmid vector
(Qiagen). The in-frame his–DHFR–Nramp2 fusion protein con-
struct was transformed into 
 
E. coli
 
 strain M15(pREP4) for expres-
sion (Qiagen). Purification was performed on Ni–NTA agarose
according to experimental conditions suggested by the manufac-
turer (Qiagen). The polyclonal antiserum directed against the
GST fusion protein was purified against the his–DHFR fusion pro-
tein by a preparative immunoblot procedure (20). The anti-
Nramp1 polyclonal antiserum (8) was affinity purified against the
corresponding Nramp1–GST fusion protein by the same protocol.
 
Cell Culture.
 
The mouse monocyte–macrophage cell lines
RAW 264.7 and J774a, the mouse Sertoli cell line TM4, and the
mouse kidney line mIMCD-3 were obtained from the American
Type Culture Collection (ATCC). They were cultured in media
and under conditions recommended by the ATCC. WEHI 3B
(myelomonocyte), WEHI 231 (B lymphocyte), BI 141 (T lym-
phocyte), and 70Z/3 (pre-B cell) cells were cultured as described
previously (21). Chinese hamster ovary (CHO) cells LR73 (22)
were grown in 
 
a
 
-MEM supplemented with 10% fetal calf serum,
2 mM L-glutamine, 50 U/ml penicillin and 50 
 
m
 
g/ml strepto-
mycin. All media and media supplements were purchased from
GIBCO BRL. Murine macrophages were obtained by peritoneal
lavage, as previously described (8). We have previously described
the production and characterization of RAW macrophages ex-
pressing a transfected wild-type Nramp1 fused to a 
 
c-myc
 
 epitope
(9). The 
 
c-myc
 
–tagged Nramp2 expression plasmid was con-
structed by excising the 
 
myc
 
-tagged 
 
Nramp2
 
 cDNA from plasmid
pBluescript (23) using 
 
Spe
 
I and 
 
Eco
 
RV sites from the polylinker,
followed by cloning into the mammalian expression plasmid
pCB6 (24). For expression in CHO cells, the same insert was
cloned into the expression vector pMT2 (25). CHO cells were
transfected by the calcium phosphate coprecipitation method
(26). RAW cells were transfected by electroporation as described
previously (9). Clones of stable transfectants were selected in ge-
neticin (G418, 1 mg crude/ml final; GIBCO BRL) for 10–14 d,
picked and expanded individually, and tested for protein expres-
sion by immunofluorescence using the anti–
 
c-myc
 
 tag monoclonal
antibody 9E10 (Babco).
 
Immunoblotting and Immunoprecipitation.
 
Crude membrane frac-
tions from the various cells were prepared as described previously
(27). Protein concentration of the membrane fraction was deter-
mined by the Bradford assay (BioRad). Proteins were separated
on SDS–polyacrylamide gels and transferred by electroblotting to
nitrocellulose membranes. For experiments where the membrane
was to be stripped and reprobed, a polyvinylidene fluoride mem-
brane was used (Westran; Schleicher and Schuell) to reduce pro-
tein loss from the membrane during stripping. Equal loading and
transfer of proteins was verified by staining the blots with Pon-
ceau S (Sigma Chemical Co.). The blots were blocked in TBST
(10 mM Tris/Cl, pH 8, 150 mM NaCl, 0.05% Tween 20, pH 8)
plus 5% skim milk powder for 1 h at room temperature. Primary
antibodies used were as follows: affinity purified rabbit anti–
mouse Nramp2 (1:100 dilution); affinity purified rabbit anti– 
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mouse Nramp1 (1:200); mouse monoclonal anti 
 
c-myc
 
–epitope
tag 9E10 (Babco; 1:100), rat anti–mouse transferrin receptor
(Biosource International; 1:200), and rat anti–mouse Lamp1 (1:
200). Anti–rabbit, anti–rat, and anti–mouse secondary antibodies
conjugated to horseradish peroxidase were used at 1:10,000 (Amer-
sham). Chemiluminescence was used for detection of immune
complexes on the immunoblot (ECL; Amersham). For immuno-
precipitation, CHO cells and Nramp1 and Nramp2 CHO trans-
fectants were metabolically labeled with [
 
35
 
S]methionine by incu-
bating overnight in 100 
 
m
 
Ci/ml of [
 
35
 
S]methionine (DuPont) in
methionine-free DMEM (GIBCO BRL) containing 10% heat-
inactivated, dialyzed fetal bovine serum, 2 mM L-glutamine, and
2 mM Hepes. Immunoprecipitation was performed exactly as de-
scribed previously (8).
 
Immunofluorescence.
 
Cells were grown on glass coverslips and
fixed with 4% paraformaldehyde in PBS for 30 min at 4
 
8
 
C. Im-
munofluorescence was performed as previously described (9)
with the following modifications: incubation with the primary
antibody was 1 h at 20
 
8
 
C for the anti–
 
c-myc
 
 mouse monoclonal
9E10 (1:200; Babco), and the anti-Lamp1 rat monoclonal (1:200),
or overnight at 4
 
8
 
C for the anti-Nramp2 antiserum (1:800) fol-
lowed by anti–mouse, anti–rat, or anti–rabbit secondary antibodies
conjugated to rhodamine (1:300) or FITC (1:200) (Jackson Immu-
nochemicals). Immunofluorescence was analyzed with a Nikon
microscope using the 100
 
3
 
 oil immersion objective. Certain
colocalization studies were carried out using a Zeiss laser confocal
microscope with a 63
 
3
 
 objective. Composites of confocal images
were assembled and labeled using PhotoShop, Metamorph, and
Freehand software. To label the lysosomal compartment, cells
were incubated with 1 mg/ml lysine-fixable FITC–dextran (Mo-
lecular Probes) in growth medium for 4 h at 37
 
8
 
C in 5% CO
 
2
 
.
After washing, cells were incubated an additional 30 min to chase
the dextran from the early endosomal to the lysosomal compart-
ments. For identification of the early and recycling endosomal
compartment, cells were incubated in serum-free medium con-
taining 50 
 
m
 
g/ml FITC–transferrin (Molecular Probes) for 30
min at 37
 
8
 
C in 5% CO
 
2
 
. Phagosomes were formed by incubating
the cells with 3 
 
m
 
m latex beads (Sigma Chemical Co.) diluted
1:200 in complete culture medium for 15 min at 37
 
8
 
C in 5% CO
 
2
 
.
After treatments to identify the specific subcellular compartments,
cells were fixed in 4% paraformaldehyde and processed for im-
munofluorescence.
 
Glycosidase Treatments.
 
Endo–
 
b
 
-acetylglucosaminidase H (Endo
H) and peptide 
 
N
 
-glycosidase F (PNGase F) were obtained from
New England Biolabs. Aliquots of membrane preparations from
J774a and CHO cells were denatured before digestion in a buffer
containing 0.5% SDS and 0.1 M 
 
b
 
-mercaptoethanol for 2 min at
70
 
8
 
C. For Endo H digestion, samples were diluted twofold and
incubated with 4,000 U of Endo H in 50 mM sodium citrate, pH
5.5, for 1 h at 37
 
8
 
C. The 
 
2
 
Endo H controls were treated identi-
cally except an equivalent volume of ddH
 
2
 
O was added in place
of Endo H. For PNGase F digestion, samples were diluted two-
fold and incubated in 50 mM sodium phosphate, pH 7.5, 1%
NP-40, with 500 U of PNGase F for 1 h at 37
 
8
 
C. The 
 
2
 
PNGase
F controls were treated identically except an equivalent volume
of ddH
 
2
 
O was added in place of PNGase F.
 
RNA Isolation and Hybridization Studies.
 
Total cellular RNA
was isolated using guanidinium–HCl solubilization and differen-
tial ethanol precipitation (28). 20 
 
m
 
g of total cellular RNA were
denatured in a formamide–formaldehyde mixture and loaded
onto denaturing agarose gels containing 0.66 M formaldehyde.
Blots were prehybridized in a solution containing 10% dextran
sulfate, 1 M NaCl, 1% SDS, and heat-denatured salmon sperm
 
DNA (200 
 
m
 
g/ml) at 65
 
8
 
C for 2–16 h. Hybridization was for 24 h
at 65
 
8
 
C in the same buffer containing the radiolabeled probe (10
 
6
 
cpm/ml of hybridization buffer; specific activity 10
 
9
 
 cpm/
 
m
 
g
DNA). Blots were washed under conditions of increasing strin-
gency up to 0.1
 
3
 
 SSC and 0.1% SDS at 65
 
8
 
C and then exposed
to Kodak XR film with two intensifying screens at 
 
2
 
70
 
8C for 18 h
to 7 d at 2808C.
Phagosome Fractionation. Phagosomes were isolated from
J774a cells by a modification of a method described previously
(9). 10 subconfluent 150 mm dishes of each cell line were fed
with a 1:200 dilution of blue-dyed latex beads (0.8 mm; Sigma
Chemical Co.) in culture medium for 1 h at 378C in 5% CO2.
The cells were then washed in PBS and harvested in the presence
of protease inhibitors (1 mg/ml leupeptin, 1 mg/ml aprotinin,
1 mg/ml pepstatin, and 100 mg/ml PMSF; all Boehringer Mann-
heim) and recovered by centrifugation (2,000 g, 5 min). The cell
pellets were washed and resuspended in homogenization buffer
(8.5% sucrose, 3 mM imidazole, pH 7.4) and homogenized by
passage through a 22G needle until 90% of the cells were broken,
as monitored by light microscopy. Nuclei and unbroken cells
were pelleted and the supernatant loaded onto a sucrose step gra-
dient as follows: the supernatant was brought up to 40% sucrose
by addition of 62% sucrose and loaded on top of a 1-ml 62% su-
crose cushion. Layers of 2 ml of 35, 25 and finally 10% sucrose
(all sucrose solutions wt/wt in 3 mM imidazole, pH 7.4, plus
protease inhibitors) were sequentially added to the top of the
tube, and the gradients were centrifuged at 100,000 g for 1 h at
48C (SW41; Beckman). Phagosomes were recovered from the
10–25% sucrose interface, washed with PBS containing protease
inhibitors, and recovered by a final centrifugation at 40,000 g in
an SW41 rotor at 48C. The final pellets were resuspended in 23
Laemmli sample buffer. Phagosomes prepared by this protocol
have been previously shown to be free of endoplasmic reticulum
(endoplasmin, BiP, and calnexin) and Golgi apparatus (galactosyl
transferase) contaminants (29).
Results
To generate an isoform-specific anti-Nramp2 antiserum,
a protein segment derived from the amino terminus of
Nramp2 was selected based on its predicted antigenicity
and its sequence divergence from Nramp1 (28% identity).
A GST–Nramp2 fusion protein containing the amino ter-
minal Nramp2 segment was produced and used for immu-
nization, and the anti-Nramp2 fraction was further isolated
from the immune serum by affinity purification against a
second immobilized Nramp2–DHFR fusion partner. The
antiserum was tested for specificity by immunoblotting
crude membrane fractions as well as by immunoprecipita-
tion of [35S]methionine–labeled cell lysates from transfected
CHO cell clones expressing either c-myc–tagged Nramp1
or c-myc–tagged Nramp2 proteins (Fig. 1). The anti–c-myc
monoclonal antibody (9E10 [30]) specifically recognized a
species of apparent molecular mass 90–100 kD in the
Nramp2-transfected CHO cells, and a protein of 85–95 kD
in the Nramp1-transfected cells that were absent from
extracts of untransfected CHO controls (Fig. 1, A and B,
bottom). These protein species migrated as broad bands in
SDS–acrylamide gels. In membrane preparations from
Nramp2-transfected CHO cells (CHON2), the affinity-834 Nramp2 Expression in Endosomes
purified anti-Nramp2 antiserum recognized a single protein
species of apparent molecular mass 90–100 kD (Fig. 1 A,
top). Immunoblotting analysis of the same set of membrane
fractions with anti-Nramp1 antiserum revealed a single pro-
tein species of 85–95 kD in membranes from the Nramp1-
transfected CHO cells (Fig. 1 A, middle). These immu-
noreactive bands were absent from untransfected CHO
cells and from transfected cells expressing the other Nramp
isoform. The electrophoretic mobility characteristics of the
Nramp1 and Nramp2 detected by the respective polyclonal
antisera were very similar to those of the species detected
by the anti–c-myc antibody in the same cell extracts (Fig. 1 A,
bottom). The reactivity and isoform specificity of the anti-
bodies were confirmed by immunoprecipitation studies of
[35S]methionine metabolically labeled cell extracts from
CHO cells or from Nramp1 and Nramp2 CHO transfec-
tants (Fig. 1 B). These data indicate that the anti-Nramp1
and anti-Nramp2 antisera produced and purified according
to our protocol are isoform specific.
Northern blotting and in situ hybridization studies have
shown that, as opposed to Nramp1, which is expressed al-
most exclusively in mononuclear phagocytes, Nramp2
mRNA is expressed in most tissues (10–12). We ques-
tioned whether the two Nramp proteins would display an
overlapping or mutually exclusive expression pattern. North-
ern blot analysis of total cellular RNA from a panel of mu-
rine hematological cell lines revealed a readily detectable
level of Nramp2 mRNA expression in the macrophage
lines RAW 264.7 and J774a as well as in Friend virus–
transformed erythroleukemia (MEL) cells (Fig. 2 A, top;
exposure time 1 wk). A much lower level of expression of
Nramp2 was found in other cell lines: WEHI 231 (B lym-
phocyte), WEHI 3B (myelomonocyte), 70/Z (pre-B lym-
phocyte), and BI 141 (T lymphocyte). In comparison,
Nramp1 mRNA expression was restricted to the macro-
phage cell lines RAW264.7 and J774a and is expressed
at levels z50-fold higher than that of Nramp2 (Fig. 2 A,
middle; exposure time 24 h). Thus, Nramp1 and Nramp2
mRNAs are coexpressed in macrophages.
To analyze Nramp2 protein expression in macrophages,
membrane fractions were prepared from thioglycolate-
induced primary mouse macrophages, from J774a and RAW
264.7 cultured macrophages. For comparison, membranes
were also prepared from cell lines derived from tissues pre-
viously shown to express a high level of Nramp2 mRNA:
the Sertoli cell line TM4 and the kidney inner medullary
collecting duct line mIMCD-3 (17). Membranes were also
prepared from control and Nramp2-transfected CHO cells,
as well as from two cell lines expressing low levels of
Nramp2 mRNA (Fig. 2 A, WEHI 231 and WEHI 3B).
The membranes were analyzed by immunoblotting with
the anti-Nramp2 antibody (Fig. 2, B and C). The antibody
detected a major heterogeneous immunoreactive protein
species of broad electrophoretic mobility with an apparent
molecular mass of 80–90 kD in all cells tested, with the ex-
ception of WEHI 231 cells and untransfected CHO cells.
The protein was most abundant in TM4, RAW 264.7,
J774a and MEL cells. The protein was also detected in the
membranes prepared from primary mouse macrophages
and mIMCD-3 cells, although at a lower level. WEHI 3B
membranes showed the lowest level of Nramp2 expression,
Figure 1. After affinity purifi-
cation, anti-Nramp1 and anti-
Nramp2 antisera were tested for
specificity and reactivity by im-
munoblotting against crude
membrane fractions (A) as well
as by immunoprecipitation of
[35S]methionine–labeled cell ly-
sates (B) from CHO cells or
from the same cells transfected
with a c-myc–tagged (tag se-
quence EQKLISEEDL) Nramp1
(CHON1) or a c-myc–tagged
Nramp2 (CHON2). Protein ex-
tracts were separated by SDS-
PAGE and either transferred to
membranes (A) or exposed to
x-ray films after immunoprecipi-
tation (B). Antisera directed
against Nramp2 (top), Nramp1 (center) or a commercially available mouse
monoclonal anti–c-myc antibody (9E10; bottom) were used. The size of
the molecular mass markers (in kD) is indicated to the right of the gels.
Figure 2. (A) Nramp2 mRNA
expression in cultured cell lines.
Northern blot analysis of total cel-
lular RNA (20 mg) from mouse
cell lines: BI 141 (T lymphocyte;
lane 1), 70/Z (pre-B lymphocyte;
lane 2), WEHI 231 (B lympho-
cyte; lane 3), WEHI 3B (my-
elomonocyte; lane 4), RAW 264.7
(macrophage; lane 5), J774a (mac-
rophage; lane 6), and MEL (erythroleukemia; lane 7). The RNA was electrophoresed in a denaturing agarose gel, fol-
lowed by transfer to a nylon membrane and hybridization to gene-specific cDNA segments from either Nramp2 (top),
Nramp1 (center), or glyceraldehyde phosphate dehydrogenase (Gapdh, bottom). Exposure time was 7 d for Nramp2 and
1 d for Nramp1 and Gapdh. (B) Nramp2 protein expression in cultured cell lines. Crude membrane fractions were pre-
pared from different cultured cell lines as well as from thioglycolate-induced primary mouse macrophages (Mø) and
were separated by SDS-PAGE. Immunoblotting was performed using the anti-Nramp2 antiserum. (C) Glycosylation
of Nramp2 protein. Membrane fractions from J774a cells (lanes 1–4) and Nramp2-transfected CHO cells (lanes 5–7)
were treated with endoglycosidases followed by electrophoresis and immunoblotting with the anti-Nramp2 antiserum.
Membrane fractions were either mock treated (lanes 1, 3, and 5) or incubated with Endo H (lane 2) or PNGaseF (lanes
4, 6, and 7). A lighter exposure of lane 6 is shown in lane 7.835 Gruenheid et al.
whereas WEHI 231 and untransfected CHO cells were
negative for Nramp2 expression. In the positive membrane
samples, the electrophoretic mobility and heterogeneity of
the immunoreactive species varied, possibly due to differ-
ent posttranslational modification of the protein in these
cell types. Thus, Nramp2 is expressed in a wide variety of
tissues, including macrophages, and macrophages coexpress
Nramp1 and Nramp2.
The apparent mass of endogenous Nramp2 estimated by
SDS-PAGE is considerably greater than the 62.3 kD molec-
ular mass predicted by the primary amino acid sequence of
the cDNA. Together with the broadness of the immunore-
active band, this anomalous mobility suggests that Nramp2
may be posttranslationally modified by glycosylation. To
test this hypothesis, membrane fractions from J774a cells
and Nramp2-transfected CHO cells were treated with en-
doglycosidases followed by electrophoresis and immuno-
blotting. Nramp2 was resistant to digestion with Endo H
(Fig. 2 C, lanes 1 and 2), which specifically cleaves high
mannose and some hybrid N-linked oligosaccharides from
glycoproteins. In contrast, PNGaseF, which hydrolyzes high
mannose, hybrid, and complex oligosaccharides, converted
the 82-kD Nramp2 species into smaller forms of approxi-
mate apparent molecular masses of 50–55 kD (Fig. 2 C, lane
4). PNGase treatment of membranes from the Nramp2
CHO transfectants also resulted in a shift of the apparent
molecular mass of the protein from 85 to z56 kD (Fig. 2 C,
lanes 6 and 7). Therefore, Nramp2 is posttranslationally
modified extensively by complex N-linked glycosylation.
To gain insight into the subcellular localization of
Nramp2, we first performed immunofluorescence studies
on CHO and RAW 264.7 transfected cells, using an anti-
body directed against the c-myc epitope attached to the car-
boxy terminus of the transfected Nramp2 protein. The
high levels of transfected protein in these cell lines facili-
tated nonambiguous localization of Nramp2, without pos-
sible limitation associated with low levels of expression of
the endogenous protein. We have previously observed that
the  c-myc–tagged Nramp2 protein is functional in both
CHO and RAW macrophage backgrounds and carries out
active Fe21 transport in these cells (Govoni, G., and P.
Gros, unpublished results). We initially tested whether
Nramp2 localizes to the late endosomal/lysosomal com-
partment, as found earlier for Nramp1 (9). To label the ly-
sosomal compartment, cells were cultured in the presence
of FITC–conjugated dextran, followed by a chase period of
30 min to remove the dextran from the early endosomal
compartments, before fixation and immunostaining with
the anti–c-myc antibody. In Nramp1-transfected CHO
cells, there was clear colocalization of the anti–c-myc stain-
ing (Fig. 3 A) and the dextran-loaded late endosomal/lyso-
somal compartment (Fig. 3 B). Nramp1-stained vesicles
negative for FITC–dextran were also detected. In contrast,
in Nramp2-transfected CHO cells, anti–c-myc staining re-
vealed an intracellular network of finer punctate vesicles
distributed throughout the cytoplasm (Fig. 3 C). This stain-
ing does not appear to colocalize with the FITC–dextran
(Fig. 3 D). Similar results were obtained in parallel experi-
ments using the c-myc–Nramp1 and c-myc–Nramp2-trans-
fected RAW cells (data not shown), indicating that
Nramp2 is not expressed in the lysosomal compartment.
Thus, Nramp1 and Nramp2 clearly appear to have distinct,
nonoverlapping subcellular sites of expression.
Since Nramp2 is implicated in cellular iron uptake, it ap-
pears logical that Nramp2 be present at the plasma mem-
brane and/or in recycling endosomes. To label these com-
partments, CHO (Fig. 4) and RAW transfected cells (Fig.
5) were cultured in the presence of FITC–conjugated
transferrin before fixation and immunostaining with the
anti–c-myc antibody. Analysis by confocal microscopy indi-
cated that, as expected, transferrin (green) stained both the
plasma membrane (ring-like staining at the edge of the
cells) and the recycling endosomes (subcellular punctate
staining) (Fig. 4 B). A very similar and overlapping pattern
was observed for Nramp2, as revealed by the anti–c-myc an-
tibody (red, Fig. 4 A). Superimposition of the two images
(Fig. 4 C) clearly identifies colocalization (yellow) of the
two signals. Certain cells stained with FITC–transferrin but
Figure 3. Subcellular localization of Nramp1 and Nramp2 in trans-
fected CHO cells. Immunofluorescence was performed on CHO cells
transfected with c-myc–tagged Nramp1 proteins (A and B), c-myc–tagged
Nramp2 proteins (C and D), or with untransfected CHO controls (E and
F). Immunofluorescence was with the anti–c-myc mouse monoclonal anti-
body 9E10 (A, C, and E) which detects the transfected Nramp1 and
Nramp2 proteins. Lysosomes were labeled by preincubation of the cells
with FITC–conjugated dextran (B, D, and F). Cells were then fixed and
reacted with the anti–c-myc tag antibody 9E10 and a rhodamine-conju-
gated secondary antibody (A, C, and E), followed by examination by flu-
orescence microscopy and photography.836 Nramp2 Expression in Endosomes
were negative for the c-myc staining, suggesting that al-
though these cells are positive for the pSV2neo plasmid and
are resistant to G418, they failed to express c-myc–tagged
Nramp2. Such cells provide an internal control for the
specificity of the anti–c-myc staining and for the overlapping
staining with FITC–transferrin. Similarly, when untrans-
fected CHO cells were identically processed and examined,
the cells were not stained with the anti–c-myc antibody (Fig.
4 D), but displayed a normal pattern of staining with
FITC–transferrin (Fig. 4 E). Finally, when the lysosomes of
the Nramp2-transfected cells were stained with FITC–dex-
tran (Fig. 4 H) and with the anti–c-myc antibody for
Nramp2 (Fig. 4 G), no significant overlap between the two
signals was detected (Fig. 4 I). A similar colocalization of
Nramp2 and FITC–transferrin was noted in parallel ex-
periments with RAW macrophages expressing c-myc–
Nramp2 (Fig. 5). These results confirm that Nramp1 and
Nramp2 have nonoverlapping, subcellular localization, and
that Nramp2 colocalizes with transferrin in the early recy-
cling endosomal compartment.
To confirm the endosomal localization of Nramp2 de-
termined in transfected CHO and RAW cells, we per-
formed immunofluorescence in nontransfected cell lines
that tested positive (MEL, TM4) or negative (WEHI 231)
for Nramp2 expression by immunoblotting (Fig. 2). Im-
munofluorescence was performed with the anti-Nramp2
polyclonal antiserum and FITC–transferrin, and results are
shown in Fig. 6. In MEL (Fig. 6, A and B) and TM4 (C
and D) cells, the endogenous Nramp2 protein (B and D)
showed very similar staining pattern to that generated by
FITC–transferrin (A and C), similar to that seen in trans-
fected cells (Figs. 4 and 5). Finally, in agreement with the
absence of Nramp2 expression in WEHI 231 cells noted by
immunoblotting (Fig. 2 B), no Nramp2 staining was ob-
served in WEHI231 cells (Fig. 6 F), although the endoso-
mal compartment of these cells could readily be labeled by
FITC–transferrin (Fig. 6 E). Together, these results verify
data obtained in transfected CHO and RAW cells.
The localization of Nramp2 to the plasma membrane
and endosomal network raised the possibility that like
Nramp1, Nramp2 may become associated with phagoso-
mal membranes after phagocytosis. Phagosomes are initially
Figure 4. Colocalization of Nramp2 and transferrin in early endosomes was determined by double immunofluorescence and confocal microscopy in
either CHO control cells (D–F) or CHO cells transfected with a c-myc–tagged Nramp2 protein (A–C and G–I). Cells were cultured in the presence of
FITC–conjugated transferrin (A–F) or FITC–conjugated dextran (G–I) before fixation and immunostaining with the anti–c-myc tag antibody and a
rhodamine-conjugated secondary antibody (A, D, and G). The slides were then examined by confocal microscopy, and the FITC (green; B, E, and H)
and rhodamine (red; A, D, and G) images were overlaid (yellow identifies colocalization; C, F, and I). In the Nramp2-transfected CHO cells, the
Nramp2 staining (A and G) showed extensive overlap with the distribution of FITC–transferrin (A 1 B 5 C) but not with lysosomal FITC–dextran (G 1
H 5 I). FITC–transferrin staining was observed in the untransfected CHO cells (E), but the cells were negative for anti–c-myc staining (D).837 Gruenheid et al.
derived from the plasma membrane and are known to se-
quentially interact and acquire proteins from both early and
late endosomes before their final fusion with lysosomes
(29). We have shown that Nramp1 is acquired during the
phagosomal maturation process, using the model system of
latex bead–containing phagosomes (9). Latex bead–con-
taining phagosomes are ideal for microscopic examination
and can also be purified from cell homogenates by flotation
on sucrose gradients. To determine whether Nramp2 can
associate with the phagosomal membrane, J774a cells were
fed latex beads for 1 h at 378C, and the phagosomal fraction
was isolated from cell homogenates by fractionation on su-
crose gradient. Equal amounts of the purified phagosomal
fraction and of a crude total membrane fraction were sepa-
rated by SDS-PAGE, and the relative amount of en-
dogenous Nramp2 in each sample was determined by im-
munoblotting. As shown in Fig. 7 A (left), Nramp2 was
significantly enriched in purified phagosomes as compared
to the crude membrane preparation. In these experiments,
the Lamp1 protein (marker of the phagolysosome, center)
and the transferrin receptor (marker of the plasma mem-
brane, right) were used as controls. As expected, significant
enrichment of Lamp1 was seen in the phagosomal fraction
whereas the transferrin receptor was not enriched in phago-
somes even though it is readily detectable in crude mem-
brane fractions. These results suggest that Nramp2 becomes
associated with the phagosome during its maturation to
phagolysosome. Possible association of Nramp2 with latex
beads phagosomes was further analyzed in J774a cells by
immunofluorescence and confocal microscopy. J774a cells
were fed latex beads and then fixed and processed by
double immunofluorescence using anti-Nramp2 and anti-
Lamp1 antibodies (Fig. 7 B). In J774a cells, the Nramp2
signal obtained with our antibody was weak, which limited
the analysis. Nevertheless, in several of the sections ana-
lyzed a portion of the Nramp2 signal could clearly be seen
Figure 5. Colocalization of
Nramp2 and transferrin in early
endosomes was determined by
double immunofluorescence and
confocal microscopy in RAW
macrophages transfected with a
c-myc–tagged Nramp2 (A–C) and
in untransfected control cells
(D–F). Cells were cultured in
the presence of FITC–conjugated
transferrin before fixation and im-
munostaining with the primary
anti–c-myc tag antibody (9E10)
and a secondary rhodamine-con-
jugated, anti–mouse antibody.
The slides were then examined
by confocal microscopy, and the
FITC (green; B and E) and
rhodamine (red; A and D) images
were overlaid to identify colo-
calization (C and F). The image
in C shows colocalization of
Nramp2 and FITC–transferrin in
several of the cells in the field.
Figure 6. Subcellular localization of endogenous Nramp2 in cell lines.
Cell lines previously shown by immunoblotting to be either positive (MEL,
TM4) or negative (WEHI 231) for Nramp2 expression were cultured in the
presence of FITC–transferrin before fixation and immunostaining with the
anti-Nramp2 antiserum and a rhodamine-conjugated secondary antibody.
The slides were then examined by confocal microscopy, and FITC (A, C,
and E; transferrin) and rhodamine (B, D, and H; Nramp2) images were ob-
tained from the samples. The same settings for the confocal microscope were
used for all samples examined. The images show very similar subcellular
localization of Nramp2 and FITC–transferrin in MEL (A and B) and TM4
(C and D) cells, whereas WEHI (E and F) cells are negative for Nramp2.838 Nramp2 Expression in Endosomes
at the periphery of the bead, suggesting association with the
phagosome. However, this signal was much weaker than
that obtained using the anti-Lamp1 antibody. Thus, results
from immunoblotting and immunofluorescence suggest the
possibility that a portion of the endosomal Nramp2 protein
becomes associated with the phagosome during phagolyso-
some maturation.
Discussion
A large body of biochemical data supports the proposal
that Nramp2 functions as a transporter for several divalent
cations, including Fe21 (12–14, 23, 31). Nramp2 is mutated
in the mk mouse and in the Belgrade rat (13, 14), with both
animals exhibiting a severe microcytic hypochromic ane-
mia and a severe defect in iron absorption by intestinal cells
(15, 16). However, in vitro studies have shown that iron
acquisition is also decreased in the peripheral cells and tis-
sues of these animals (17, 32–36) and that the anemia can-
not be corrected by direct iron injections (37), suggesting a
second block of iron entry into peripheral tissues. Thus,
physiological consequences of Nramp2 mutations in vivo
strongly suggest that Nramp2 is not only involved in iron
uptake at the level of the intestinal enterocyte but also par-
ticipates in iron acquisition in other cell types as well. In
peripheral tissues, cellular iron uptake is through the trans-
ferrin cycle (for review see reference 38). Diferric transfer-
rin binds to the transferrin receptor and is internalized, and
acidification of the internalized vesicles results in release of
iron from transferrin followed by alkalinization of the vesi-
cles and recycling of the receptor to the cell surface (39).
Iron escapes the acidified endosomal compartment to reach
the cytoplasm, where it can be captured by mitochondria
for heme biosynthesis and incorporation into heme-con-
taining proteins, stored in the cytoplasm in the form of
ferritin, and/or used directly for synthesis of nonheme-
containing proteins (e.g., ribonucleotide reductase). The
mechanism by which iron is extruded from the acidified
endosome to enter the cytoplasm is unknown and has been
a matter of considerable debate.
In the current study, we have raised isoform specific
anti-Nramp2 antiserum and have used it to verify a number
of structural and biochemical features of Nramp2 predicted
from the primary amino acid sequence deduced from the
cDNA. These analyses have shown that Nramp2 is an inte-
gral membrane protein which is extensively modified by
N-linked glycosylation. As opposed to Nramp1, which is
macrophage-specific, Nramp2 protein was found ubiqui-
tously expressed in a majority of cell lines analyzed. The
current study has also clearly established that Nramp2
and Nramp1 localize to distinct subcellular compartments.
Whereas Nramp1 colocalizes with FITC–dextran in the ly-
sosomal compartment, Nramp2 is not detectable in this
compartment but rather shows clear colocalization with
FITC–transferrin both at the plasma membrane and in re-
cycling endosomes. The demonstration of Nramp2 expres-
sion in several peripheral tissues, the colocalization of
Nramp2 and transferrin in plasma membrane and recycling
endosomes, the iron transport properties of the Nramp2
protein, and the effect of Nramp2 mutations on iron me-
tabolism in peripheral tissues are strong evidence that
Nramp2 is responsible for transporting Fe21 into the cyto-
plasm after acidification of the transferrin-positive endo-
some (Fig. 8). Interestingly, this acidification would simul-
taneously provide a gating mechanism for iron transport by
Nramp2 and for release from transferrin (Fig. 8). Indeed,
the pH dependence of iron transport by Nramp2 has been
demonstrated in several systems, including Xenopus oocytes
(12), transfected HEK293T cells (14), and CHO cells (Go-
voni, G., and P. Gros, unpublished results). Likewise, re-
lease of iron from transferrin and its subsequent release
from endosomes is dependent on endosome acidification,
which can be inhibited by bafilomycin (40) and concana-
mycin (41), specific inhibitors of the vacuolar H1–ATPase,
but is insensitive to the Na1, K1–ATPase inhibitor ouabain
(41, 42). This suggests a critical role for the vacuolar H1–
ATPase in this process. Indeed, the association of vacuolar
H1–ATPase with transferrin-positive endosomal vesicles
has been demonstrated by immunohistochemical means in
LLC–porcine kidney epithelial 1 cells (43).
Figure 7. Nramp2 association with phagosomes. (A) Immunoblotting of latex bead–containing phagosomes isolated from J77a cells. Latex bead–con-
taining phagosomes were purified from cell homogenates by subcellular fractionation on sucrose density gradients as described in Materials and Methods.
Equal amounts of phagosomal proteins (P) and of a crude membrane protein extract prepared prior to phagocytosis (M) were separated by SDS-PAGE on
a 7.5% gel. Proteins were transferred to nitrocellulose and the immunoblot was sequentially analyzed with anti-Nramp2 antiserum (left), anti-Lamp1 an-
tibody (center), and anti-transferrin receptor antibody (right). The position of molecular mass markers (in kD) is indicated on the left side of the immu-
noblot. (B) Localization of the Nramp2 and Lamp1 proteins in J774a macrophages by immunofluorescence. J774a macrophages were allowed to phago-
cytose latex beads, then fixed and stained with the anti-Nramp2 antiserum and a rhodamine-conjugated secondary antibody (a), and the anti-Lamp1
antibody and a secondary antibody coupled to FITC (b). A phase contrast image of the cells shown in panels a and b is also included in panel c.839 Gruenheid et al.
The demonstration that Nramp1 and Nramp2 are coex-
pressed in the same cell type with distinct subcellular lo-
calizations suggests possible functional parallels between
Nramp1 and Nramp2 (Fig. 8). Both the yeast Smf1 and the
mammalian Nramp2 proteins can transport Mn21, with the
latter also transporting Fe21 and other divalent cations.
Nramp2 and Smf1 share approximately 40% sequence
identity within the conserved hydrophobic core (18). As
the mammalian Nramp1 and Nramp2 proteins share almost
80% sequence identity within their hydrophobic cores, it is
likely that Nramp1 is involved in the transport of divalent
cations as well. The removal of such metabolically essential
ions from the phagosomal space would provide an attrac-
tive explanation for the observed pleiotropic effect of
Nramp1 mutations in vivo on the replicative potential of
internalized microbes that inhabit the phagosomal space in
macrophages. Additionally, the observation that a portion
of Nramp2 associates with latex bead phagosomes in J774a
cells suggests that Nramp2 may also play a role in depleting
the phagosomal space of divalent cations necessary for mi-
crobial survival.
Despite considerable efforts, transport studies in CHO
and RAW cells transfected and overexpressing Nramp1
protein have so far failed to demonstrate an Nramp1-medi-
ated transport of either 54Mn or 55Fe transport in these cells
(Govoni, G., and P. Gros, unpublished results). The dis-
tinct, nonoverlapping distribution of Nramp1 and Nramp2
reported here provides an explanation for this apparent lack
of transport activity associated with Nramp1. While the
two proteins may have the same transport potential, the
observed targeting of Nramp2 to the plasma membrane and
recycling endosome compartment would result in a net in-
crease in cellular accumulation of extracellularly added, ra-
diolabeled ligand under acidic pH transport assay condi-
tions. On the other hand, the restricted expression of
Nramp1 to the lysosomal compartment would not cause a
similar increased cellular uptake of a ligand presented in the
extracellular milieu, although it could act on such ligand if
present in the phagolysosomal space. Therefore, it is tempt-
ing to speculate that both Nramp1 and Nramp2 have simi-
lar transport function but act at different, nonoverlapping,
intracellular sites (Fig. 8). If Nramp1 and Nramp2 do in-
deed transport the same substrates, it is also tempting to
speculate that vesicular acidification via the vacuolar H1–
ATPase may provide a key common gating mechanism for
the activation of both transporters, through fusion with
vacuolar H1–ATPase-positive vesicles (Fig. 8). Possible
similarities and differences in the mechanism of action and
regulation of Nramp1 and Nramp2 in macrophages are
currently being investigated.
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